Navigation Links
Carnegie's Doug Koshland elected Fellow of the American Academy of Microbiology
Date:2/5/2009

Baltimore, MDDouglas E. Koshland, staff scientist at Carnegie's Department of Embryology, has been elected one of 72 Fellows by the American Academy of Microbiology. Fellows are annually elected "through a highly selective, peer-review process, based on their records of scientific achievement and original contributions that have advanced microbiology."

Using the simple, single-celled yeast Saccharomyces cerevisiae, Koshland has become a leader in studying the molecular processes that control the dynamics of chromosome structure and evolutionthe foundations for understanding developmental problems and diseases such as cancer. He is interested in how genetic integrity is maintained during cell-division, particularly when duplicated chromosomes, known as sister chromatids, are produced, remain connected, and then separate to make two new cells.

"At a time when few believed it possible, Koshland showed how yeast could be used to reveal some of the most fundamental and important gene products and mechanisms governing animal (and human) chromosomes," remarked department director Allan Spradling. "If there was a way to measure a scientist's overall contribution of novel ideas and critical thought to his field, Doug Koshland would rank at the very top."

"All of us at Carnegie are proud of Doug's accomplishments. I know that this recognition by the American Academy of Microbiology is richly deserved," commented Carnegie president Richard A. Meserve.

Koshland has been a staff scientist at Carnegie since 1987 and a Howard Hughes Medical Institute investigator for about half that time. He is also an adjunct professor in the Department of Biology at the Johns Hopkins University. Among his many affiliations, Koshland is a member of the American Academy of Arts and Sciences and a fellow of the American Association for the Advancement of Science. He serves on numerous editorial boards. Koshland received his B.A. from Haverford College
'/>"/>

Contact: Tina McDowell
tmcdowell@ciw.edu
202-939-1120
Carnegie Institution
Source:Eurekalert  

1

GOOD

Page: 1 2

Related biology news :

1. Carnegies Field and Koshland Elected AAAS Fellows
2. 3 Columbia University Medical Center faculty elected to Institute of Medicine
3. Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree
4. Rwandas Gishwati Forest selected as site for historic conservation project
5. 19 researchers selected as 2008 Leopold Leadership Fellows
6. Motorola Biometric Identification System Selected by West Virginia State Police
7. Motorola Biometric Identification System Selected by West Virginia State Police
8. Nobel laureate Dr. Linda Buck elected to American Academy of Arts & Sciences 2008 Class of Fellows
9. UT Southwesterns Mangelsdorf elected to National Academy of Sciences
10. UMass Medical Schools Craig Mello elected to American Academy of Arts and Sciences
11. Atmels FingerChip Biometric Sensor Selected by Rise Computer for its Robust Security
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Carnegie's Doug Koshland elected Fellow of the American Academy of Microbiology
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
(Date:5/21/2013)... method for delivering molecules into single, targeted cells ... technique could find applications in drug delivery, cell ... a technique used to deliver molecules into ... that are caused by exposing them to electric ... cell transfection. (Cell transfection is the introduction of ...
(Date:5/21/2013)... University of Illinois at Chicago College of Medicine will study ... -- its main energy source -- and how changes in ... new $2 million, 4-year grant from the National Heart, Lung ... it uses fuel for energy. These changes may play a ... different in men and women, says E. Douglas Lewandowski, director ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2Do men's and women's hearts burn fuel differently? 2
... raged over whether organic compounds and tiny globules of ... 84001 were processed by living creatures from the Red ... scrutiny ever since. Scientists at the Carnegie Institution's Geophysical ... how material associated with carbonate globules was created using ...
... more than 100 people have been infected with the H5N1 ... the fact that the virus does not spread easily from ... biomedical puzzle. , Now, a study of cells in the ... cells of the system that makes it difficult for the ...
... North America, two types of invasive vines are growing ... populations and bird habitats. , The vines are pale ... to stem the growth of and their steady conquest ... Canada, Cornell University is teaming up with the U.S. ...
Cached Biology News:Relic of life in that Martian meteorite? A fresh look 2Cell barrier shows why bird flu not so easily spread among humans 2Cell barrier shows why bird flu not so easily spread among humans 3CU, USDA team to curb two invasive, poisonous vines 2CU, USDA team to curb two invasive, poisonous vines 3
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)... study led by George Washington University Professor Tianshu ... ice in small droplets is strongly size-dependent, an ... nanoscale. The formation of ice at the nanoscale ... answer also has important implications for climate research ... ice from supercooled water is generally initiated by ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, ... that Genzyme, a Sanofi company and leading biotech company, ... for a multi-use facility in the United States. With ... buildings, this latest order underscores the satisfaction and success ... device improving doorway access control. , “We ...
(Date:5/21/2013)... Md. , May 21, 2013  MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM.  The presentation ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
... A non-invasive blood,monitoring device that removes the need ... 2008 Kerrin Rennie Award for Excellence in Medical ... 24 September at the,Medical Technology Association of Australia ... CO-Oximeter from Masimo Corporation continuously,and non-invasively measures blood ...
... -, MONTVALE, N.J., Sept. 26 Memory,Pharmaceuticals Corp. ... completed,its Phase 1 multiple ascending dose study of R4996/MEM ... the fourth and final study,in the Company,s Phase 1 ... alpha-7 receptor being developed in collaboration with Roche.,Memory Pharmaceuticals ...
... a first, researchers at the University of Iowa and the ... cystic fibrosis (CF) that appears to closely mimic the disease ... the CF piglets and human newborns with CF suggest that ... and may also speed discovery of new treatments. The study ...
Cached Biology Technology:No Blood Needed Thanks to Innovative Medical Technology 2Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908 2Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908 3Researchers develop new model for cystic fibrosis 2
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
...
...
Biology Products: